Month: January 2009

CRC & Follow-Up Screening

Patients with colorectal cancer (CRC) who undergo potentially curative surgery have been shown to have an increased risk of disease recurrence. To reduce this risk, several professional societies have issued guidelines that...

Read More

Making the Case for Point-of-Care Testing

The Piccolo xpress (Abaxis) comprehensive metabolic panel (CMP) recently became the first CMP to be granted Clinical Laboratory Improvement Amendments (CLIA)-waived status by the FDA. With this waiver, providers can now conduct...

Read More

For latest news and updates

Email-id is invalid